The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal-Reference-Cited by-同舟云学术

The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

Published:2008-03-25 Issue:1 Volume:114 Page:31-38
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Peixoto Ana,Santos Catarina,Rocha Patrícia,Pinheiro Manuela,Príncipe Sofia,Pereira Deolinda,Rodrigues Helena,Castro Fernando,Abreu Joaquim,Gusmão Leonor,Amorim António,Teixeira Manuel R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-9978-4.pdf

Reference25 articles.

1. Tonin P, Serova O, Lenoir G et al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189

2. Durocher F, Tonin P, Shattuck-Eidens D et al (1996) Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet 33:814–819

3. Tonin PN, Mes-Masson AM, Futreal PA et al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63:1341–1351

4. Dørum A, Hovig E, Tropé C et al (1999) Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or1135insA. Eur J Cancer 35:779–781

5. Peelen T, Cornelis RS, van Vliet M et al (1996) The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1or BRCA2. Eur J Hum Genet 4:225–230

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases;Breast Cancer Research and Treatment;2024-06-14

2. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health;BMC Genomics;2024-04-27

3. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service;Scientific Reports;2022-11-03

4. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points‐based ACMG/AMP approach;Human Mutation;2022-10-23

5. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci;JNCI: Journal of the National Cancer Institute;2022-10-10